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Abstract: 
Eflornithine is one of two registered drugs for the treatment of late-stage human African 
trypanosomiasis, a uniformly fatal neglected disease with sixty million people are at risk of 
being infected. Eflornithine is efficacious but the cumbersome intravenous administration 
leaves numerous patients untreated. A simplified mode of administration, preferably oral, 
would enable more patients having access to treatment. The trypanostatic agent eflornithine is 
administered as a racemate where the L – form has a several-fold greater in vitro potency 
compared to the D – enantiomer. Despite the difference in potency of the enantiomers, the 
stereoselective pharmacokinetics of eflornithine has not been considered.  
 
This thesis aimed to study L – and D – eflornithine pharmacokinetics in the rat, in Caco-2 
cells and in late-stage human African trypanosomiasis patients. A secondary aim was also to 
develop a general method for predicting drug tissue to plasma concentration ratios.  
 
In the rat, eflornithine displayed stereoselective absorption where the more potent L – form 
had an approximately 50% lower fraction absorbed compared to D – eflornithine. The 
stereoselective mechanism was not detected in the present Caco-2 cell assay. Late-stage HAT 
patients, treated with racemic oral eflornithine, had an approximate 50% lower exposure of L 
– compared to D – eflornithine, similar to those in rat. The findings suggested that previous 
attempts to develop an oral eflornithine dosage regimen have failed due to unfavorable 
stereoselective absorption. High plasma exposure for both L – and D – eflornithine were 
significantly correlated to the probability of being cured.  
 
For the secondary aim of this thesis, the novel method to predict drug tissue distribution, 
based on a measured volume of distribution in combination with drug lipophilicity performed 
reasonably well. Predicted drug tissue to plasma concentration ratios agreed reasonably well 
with experimentally determined values with 85% being within a factor of ±3 to experimental 
values (n=148).  
 
In conclusion, this thesis present the stereoselective pharmacokinetics of eflornithine that can 
give information on whether a much needed oral eflornithine can be developed or not. In 
addition, the thesis also presents a general method to predict drug tissue to plasma 
concentration ratios.  
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